The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer
ConditionGastric Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorYunnan Cancer Hospital
About this trial
Spectral CT was used to prospectively collect medical images and clinical data related to gastric cancer, evaluate the effect of image quality in the diagnosis of gastric cancer, and evaluate the application value in the accurate staging of gastric cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
(a)Patients with pathologically confirmed gastric cancer;
(b) aged ≥ 18 years old;
(c) have not received chemoradiotherapy or surgery.
Disqualifiers
(a)Combined with other primary tumors;
(b) The image quality does not meet the diagnostic criteria;
(c)Those who cannot tolerate CT examination.
Trial design
Design model
Single group
Treatments tested in this trial
To explore the value of spectral CT in the diagnosis and treatment of gastric cancer
Diagnostic testCT scan of the abdomen outside of standard treatment options
Treatment groups
150 Participants
are divided into 1 treatment groupGroup A: The application value of spectral CT in the accurate staging of gastric cancerExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Pathological TNM staging
Pathological examination information: The pathology results using surgery/biopsy data are the gold standard, and the depth of tumor invasion, lymph node metastasis, and distant metastasis are recorded
Time frame
1 daySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: